| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8713994 | Journal of Allergy and Clinical Immunology | 2017 | 46 Pages |
Abstract
These data suggest that cytotoxic T-lymphocyte-associated protein 4-Ig should be evaluated as a potential treatment of inflammatory symptoms in patients with LS and those with OS.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Stéphanie MD, PhD, Susann MSc, Josselyn E. MSc, Frédéric MD, PhD, Emanuela PhD, Adrian PhD,